Search hospitals > Minnesota > Fergus Falls
Lake Region Healthcare Corporation-Cancer Care
Claim this profileFergus Falls, Minnesota 56537
Global Leader in Thyroid Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Breast cancer
Conducts research for Stomach Cancer
131 reported clinical trials
2 medical researchers
Summary
Lake Region Healthcare Corporation-Cancer Care is a medical facility located in Fergus Falls, Minnesota. This center is recognized for care of Thyroid Cancer, Lung Cancer, Breast Cancer, Breast cancer, Stomach Cancer and other specialties. Lake Region Healthcare Corporation-Cancer Care is involved with conducting 131 clinical trials across 310 conditions. There are 2 research doctors associated with this hospital, such as Bret E. Friday and Bret EB Friday.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Bret E. FridayEssentia Health Cancer Center6 years of reported clinical research
Expert in Thyroid Cancer
Expert in Lung Cancer
125 reported clinical trials
200 drugs studied
Bret EB FridayEssentia Health - Deer River Clinic1 year of reported clinical research
Studies Colorectal Cancer
Studies Glioblastoma
3 reported clinical trials
1 drug studied
Clinical Trials running at Lake Region Healthcare Corporation-Cancer Care
Breast Cancer
Bladder Cancer
Lung Cancer
Bladder Carcinoma
Cutaneous Melanoma
Thyroid Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Kidney Cancer
Breast cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Lake Region Healthcare Corporation-Cancer Care?
Lake Region Healthcare Corporation-Cancer Care is a medical facility located in Fergus Falls, Minnesota. This center is recognized for care of Thyroid Cancer, Lung Cancer, Breast Cancer, Breast cancer, Stomach Cancer and other specialties. Lake Region Healthcare Corporation-Cancer Care is involved with conducting 131 clinical trials across 310 conditions. There are 2 research doctors associated with this hospital, such as Bret E. Friday and Bret EB Friday.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.